FDA Grants Full Approval To Leqembi, The First Alzheimer's Drug Shown To Slow Cognitive Decline
(CTN NEWS) - The Food and Drug Administration (FDA) has endorsed the intravenous (IV) drug Leqembi for patients with mild dementia and early Alzheimer's
United Kingdom United States Teresa Buracchio Denis Balibouse Geriatrics Of The University Hospital Department Of Readaptation
Source: chiangraitimes.com